Skip to content
All resources

Growth hormone peptides

Ipamorelin Half-Life and Selectivity: What the Evidence Actually Measures

EC

By

· 2 min read

A summary of published research, with citations. It states no amount, schedule or route, and makes no claim about what this compound does in a person. Supplied for laboratory research use only.

On this page · 6 sections
  1. The receptor distinction
  2. Selectivity is assay-dependent
  3. Why half-life is easily oversimplified
  4. Clinical conclusions still need trials
  5. Frequently asked questions
  6. Further reading

Quick answer: Ipamorelin is a growth-hormone-secretagogue receptor agonist studied for growth-hormone release. Selectivity in a specific endocrine experiment is not proof of freedom from adverse effects or clinical efficacy.

A 96-well plate going into a plate reader
Illustration: selectivity is measured in assays like this one.

The receptor distinction

Ipamorelin acts through the ghrelin/growth-hormone-secretagogue receptor system, which differs from the GHRH receptor targeted by sermorelin and CJC-1295 analogues. A comparison must specify which biological pathway was measured.

Selectivity is assay-dependent

Published observations about growth-hormone responses and comparator hormones depend on doses, timing, subjects and sampling protocols in the underlying studies. Avoid repeating absolute statements like “no cortisol effect” without identifying the experiment and its confidence limits.

Why half-life is easily oversimplified

A pharmacokinetic half-life describes measured concentration decline under specified conditions. It is not identical to the duration of receptor signalling or the period over which a hormone biomarker remains changed. Online half-life figures often omit the population and assay that generated them.

Clinical conclusions still need trials

Changes in circulating growth hormone do not by themselves establish changes in strength, body composition, recovery or ageing outcomes. Ipamorelin research remains distinct from authorization of a finished medicinal product.

Frequently asked questions

Does ipamorelin activate the GHRH receptor? No. It acts through a different receptor system.

Does a short half-life mean a short biological response? Not necessarily. Exposure and downstream biomarker responses are different quantities.

Supplied here for laboratory use: Ipamorelin and CJC-1295 / Ipamorelin Blend. The laboratory's certificate for each lot is linked from its product page. For laboratory research use only.

Further reading

All products sold by NovaEvum are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.